Arie Belldegrun, Director at Cougar Biotechnology, Inc. (CGRB), bought 5,000 shares at $27.00 ($135K) on 2008-02-21, disclosed to the SEC on 2008-03-14.
Open-market purchase of $135k CGRB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.99 | 300 | $8K | 6.0% |
| 2 | $27.00 | 4,700 | $127K | 94.0% |
| Total | $27.00 avg | 5,000 | $135K | 100% |
| Filing → |
| ALLO | BUY | 2020-06-04 | $6.9M | — | Filing → |
| ALLO | BUY | 2019-02-13 | $3.5M | — | Filing → |
| KITE | SELL | 2017-09-27 | $9.5M | — | Filing → |